A Study of a Rilpivirine Extended-Release Suspension in Healthy Participants

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this study is to characterize the single dose pharmacokinetics (PK) and evaluate the safety and tolerability of subcutaneous administration of rilpivirine (RPV) long-acting (LA) or RPV LA in combination with cabotegravir (CAB) LA extended release suspensions in different conditions in healthy adult participants.
Epistemonikos ID: 42a4d87ca6c4194226413669af23e44368be6818
First added on: May 09, 2024